Related Experiment Video
Updated: Aug 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGF-beta in mammary gland development and breast cancer
Rosa Serra1, Michael R Crowley
1Department of Cell Biology, University of Alabama at Birmingham, 1918 University Blvd., Birmingham, Alabama 35294-0005, USA. rserra@cellbio.bhs.uab.edu
Abstract:
TGF-beta is now recognized as an important factor regulating normal mammary gland development as well as breast cancer. In development, TGF-beta regulates branching morphogenesis and differentiation by acting on both epithelial and stromal cells. TGF-beta also regulates apoptosis and matrix remodeling during involution at the end of the pregnancy cycle. TGF-beta has biphasic effects on tumor progression, acting as a tumor suppressor in early stages of cancer and promoting invasion and metastasis at later stages. Furthermore, TGF-beta may play a role in tumor progression through effects on the microenvironment. The tumor promoting effects of TGF-beta may provide a therapeutic target for late stage breast cancer via TGF-beta antagonists like the soluble receptors recently described. Future experiments will uncover the precise mechanisms of TGF-beta action in development and neoplastic disease providing more opportunities for prevention and treatment of breast disease.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
The Tumor Microenvironment

